The larvae eat living flesh, not dead tissue—they spread quickly and cause real suffering.
A parasite that once plagued American livestock before being eradicated in the mid-twentieth century has quietly returned, appearing in New Mexico dogs and prompting federal regulators to act swiftly. The FDA's emergency authorization of nitenpyram — a drug already familiar to veterinary medicine as a flea treatment — marks the first time a generic medication has been formally approved to combat the New World screwworm in companion animals. It is a reminder that the boundaries of eradication are never permanent, and that the tools of one era must sometimes be repurposed to meet the threats of another.
- The New World screwworm, a flesh-eating parasite absent from U.S. soil for roughly sixty years, has resurfaced in New Mexico dogs, triggering federal emergency action.
- Unlike fleas or ticks, screwworm larvae feed on living tissue and body fluids, causing rapid, painful infestations that can affect any warm-blooded creature — including, rarely, humans.
- The FDA moved quickly through its emergency use pathway to authorize nitenpyram tablets, repurposing a flea drug already on the market since 2000 to fill a critical treatment gap.
- Two doses given six hours apart kill most larvae within hours, but the drug offers no lasting protection — a treated pet remains fully vulnerable to reinfection.
- Veterinary follow-up is still required after treatment to manually remove surviving or dead larvae, meaning the drug is a first response, not a complete solution.
For the first time, pet owners facing a screwworm infestation have a generic medication available to them. The FDA this week granted emergency use authorization for nitenpyram tablets to treat New World screwworm larvae in dogs and cats — the first generic animal drug approved for this particular parasite, which had largely disappeared from American soil before recently reappearing in New Mexico.
Nitenpyram is not a new compound. The FDA approved it in 2000 under the brand name Capstar to treat fleas. What is new is its authorized use against screwworms, a far more destructive threat. Eligible pets must weigh at least two pounds and be at least four weeks old. A first tablet is given, followed by a second dose six hours later; most larvae are dead within hours of that initial treatment. Evidence from Brazilian studies on infected cats and dogs supported the drug's effectiveness, showing most maggots expelled after treatment.
The screwworm is a grim parasite. Females lay eggs in open wounds or mucous membranes, and the larvae that emerge consume living flesh rather than dead tissue. They can infest cattle, wildlife, pets, and occasionally humans, spreading quickly and causing serious suffering. The parasite was a recurring plague for American cattle ranchers from the 1930s through the 1960s, until a coordinated eradication campaign succeeded. Its recent reemergence in New Mexico dogs prompted the FDA to fast-track authorization.
The drug's critical limitation is that it provides no ongoing protection. Once the current larvae are eliminated, a pet remains vulnerable to new infestation. Veterinary follow-up to manually remove any remaining larvae is still necessary, making nitenpyram a tool for managing an active infestation — not a preventive shield against the next one.
For the first time, pet owners facing a screwworm infestation now have a generic medication to reach for. The FDA granted emergency use authorization this week for nitenpyram tablets, a drug that can kill the larvae of the New World screwworm in dogs and cats. The authorization marks the first generic animal drug approved to treat this particular flesh-eating parasite, which had largely vanished from American soil for decades before recently reappearing in New Mexico.
Nitenpyram itself is not new. The FDA approved it back in 2000 under the brand name Capstar, but for a different purpose—treating fleas. What's changed is the emergency authorization to use it against screwworms, a parasite far more destructive than fleas. The drug can be given to dogs and cats weighing at least two pounds and at least four weeks old. The mechanics are straightforward: a pet owner gives the first tablet, then administers a second dose six hours later. The drug works fast. According to FDA testing, most of the larvae are dead within hours of that first dose.
The screwworm itself is a grim creature. The female lays her eggs in open wounds or mucous membranes, and the larvae that hatch eat living flesh and body fluids rather than dead tissue. They can infest any warm-blooded animal—cattle, wildlife, pets, and occasionally humans, though human cases are rare. Once a female mates, she lays eggs throughout her month-long life. The infestation spreads quickly and causes real suffering.
Brazil provided the evidence that nitenpyram could work. Studies there on infected cats and dogs showed that most maggots were expelled after treatment, with the remaining larvae dying. But the drug has a significant limitation: it doesn't prevent new infestations. Once the current generation of larvae is dead, a pet remains vulnerable to reinfection. That's why the FDA notes that after nitenpyram treatment, a veterinarian will likely need to manually remove any remaining live or dead larvae from the wound.
The screwworm's return to the United States is itself a story worth noting. From the 1930s through the 1960s, the parasite was an annual plague for cattle ranchers across the country. A coordinated eradication effort eventually succeeded, and for decades the screwworm seemed to be a problem of the past. Then, in recent weeks, new cases turned up in dogs in New Mexico. The emergence prompted the FDA to fast-track the authorization for nitenpyram, using its emergency use pathway to speed access to a treatment in an urgent situation. The drug is now available, but it is not a permanent solution—only a tool to manage an infestation once it occurs.
Citações Notáveis
Nitenpyram works quickly, killing most screwworm larvae within hours of the first dose. Pet owners should administer a second dose six hours after the first.— FDA statement
The drug does not provide ongoing protection against new infestations.— FDA
A Conversa do Hearth Outra perspectiva sobre a história
Why does a drug that's been around since 2000 suddenly need emergency authorization now?
Because it was approved for fleas, not screwworms. The FDA had to evaluate whether it actually works against this particular parasite. The Brazilian studies gave them the evidence they needed to move fast.
So the drug kills the larvae quickly, but then what? The pet is still at risk?
Exactly. Nitenpyram is a treatment, not a prevention. Once you've cleared the infestation, your pet can get reinfected immediately if exposed again. You need a vet to clean out any remaining larvae, and then you have to keep the wound protected.
Why did the screwworm come back? I thought it was eradicated.
It was, for decades. But the parasite still exists in Central and South America. Something—maybe climate, maybe travel, maybe just chance—brought it back across the border. New Mexico is where we're seeing it now, in dogs.
Can humans get it?
Rarely, but yes. It can infest any warm-blooded animal. That's part of why this authorization matters. It's not just about pets—it's about stopping the parasite from spreading more widely.
What happens to a pet owner who can't get to a vet right away?
That's the real problem. The drug works, but it's not a complete solution on its own. You need veterinary follow-up. If someone can't access that care, their pet could still suffer.